Stock data
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE) reported revenue of US$0.00M and net income of -US$90.35M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$103.33M | -US$90.35M | — |
| 2024 | US$0.93M | — | -US$82.61M | -US$75.14M | — |
| 2023 | US$0.00M | — | -US$55.58M | -US$36.32M | — |
| 2022 | — | — | -US$56.52M | -US$55.19M | — |
| 2021 | — | — | -US$60.70M | -US$60.69M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$34.49M | — |
| 2026-03-31 | — | -US$30.93M | — |
| 2025-12-31 | — | -US$24.73M | — |
| 2025-09-30 | US$0.00M | -US$20.95M | — |
| 2025-06-30 | US$0.00M | -US$22.02M | — |
| 2025-03-31 | — | -US$22.65M | — |
| 2024-12-31 | — | -US$19.51M | — |
| 2024-09-30 | US$0.00M | -US$20.22M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.